US 12,343,536 B2
Neurostimulation system
Bert Bakker, Wijk en Aalburg (NL); Michel Decre, Eindhoven (NL); and Jose Antonio Garrido Ariza, Barcelona (ES)
Assigned to INBRAIN NEUROELECTRONICS S.L., Barcelona (ES)
Filed by INBRAIN Neuroelectronics S.L., Barcelona (ES)
Filed on May 27, 2022, as Appl. No. 17/827,549.
Claims priority of application No. 21382494 (EP), filed on Jun. 3, 2021.
Prior Publication US 2022/0387791 A1, Dec. 8, 2022
Int. Cl. A61N 1/36 (2006.01); A61N 1/05 (2006.01); A61N 1/372 (2006.01); A61N 1/378 (2006.01)
CPC A61N 1/3606 (2013.01) [A61N 1/0531 (2013.01); A61N 1/0534 (2013.01); A61N 1/36146 (2013.01); A61N 1/37223 (2013.01); A61N 1/3787 (2013.01)] 22 Claims
OG exemplary drawing
 
1. A neuromodulation system, in particular for Cortical and/or Deep Brain Stimulation and/or Modulation, comprising:
at least one implant unit comprising:
at least one first antenna, and
at least one lead having at least one electrode array with at least one electrode; and
at least one wearable device comprising at least one second antenna,
wherein the at least one wearable device is configured to wirelessly control and wirelessly communicate with the at least one implant unit,
wherein the at least one electrode is made of hydrothermally reduced graphene oxide, which is activated causing charged ions to permeate into the structure of the hydrothermally reduced graphene oxide, and
wherein the hydrothermally reduced graphene oxide is electrochemically activated in an electrolyte solution.